Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$306.88 - $380.0 $6,137 - $7,600
20 Added 40.0%
70 $26,000
Q4 2019

Feb 06, 2020

SELL
$281.18 - $322.05 $1,687 - $1,932
-6 Reduced 10.71%
50 $16,000
Q3 2019

Nov 05, 2019

BUY
$294.25 - $341.49 $1,765 - $2,048
6 Added 12.0%
56 $17,000
Q2 2019

Aug 08, 2019

SELL
$279.29 - $336.89 $2,234 - $2,695
-8 Reduced 13.79%
50 $17,000
Q1 2019

May 15, 2019

BUY
$246.18 - $297.25 $1,969 - $2,378
8 Added 16.0%
58 $17,000
Q3 2017

Oct 24, 2017

BUY
$231.6 - $253.39 $11,580 - $12,669
50
50 $12,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.62B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.